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ABSTRACT
Objective: Studies on decisional capacity have primarily focused on cognitive disorders, whereas
noncognitive disorders remain understudied. The purpose of our study was to assess decisional
capacity across a wide spectrum of medical and psychiatric disorders.
Method:More than 2,500 consecutive consults were screened for decisional capacity, and 336
consults were reviewed at Bellevue Hospital Center in New York. Sociodemographic and
medical variables, medical and psychiatric diagnoses, as well as decisional capacity
assessments were recorded and analyzed.
Results: Consults for decisional capacity were most commonly called for in male patients with
cognitive and substance abuse disorders. Less commonly, consults were called for patients with
mood or psychotic disorders. Overall, about two thirds of patients (64.7%) were deemed not to
have decisional capacity. Among medical diagnoses, neurological disorders contributed to
decisional incapacity, and among the psychiatric diagnoses, cognitive disorders were most
frequently documented in cases lacking decisional capacity (54.1%) and interfered more
commonly with decisional capacity than substance abuse or psychotic disorders (37.2 and 25%).
In contrast, patients with mood disorders usually retained their decisional capacity (32%).
Generally, the primary treatment team’s assessment was accurate and was confirmed by the
psychiatric service.
Significance of results: Although decisional capacity assessments were most commonly
requested for patients with substance abuse and cognitive disorders, the latter generally
affected the ability to make healthcare decisions the most. Further, cognitive disorders were
muchmore likely to impair the ability to make appropriate healthcare decisions than substance
abuse or psychotic disorders.
KEYWORDS: Assessment, Decisional capacity, Competence, Psychiatric comorbidities, Med-
ical illness
INTRODUCTION
The most critical aspect of assessing decisional
capacity is provision of the necessary care for those
lacking the ability to make decisions about what
is the most appropriate treatment to suit their
circumstances. As a central concept in healthcare
law and ethics, decisional capacity can be defined as
the ability of patients to make healthcare decisions
that are in the own best interest. The laws of theUnit-
ed States presume that adults have the ability to
make their own healthcare decisions (Cruzan
v. Director, Missouri Department of Mental Health,
1990). According to the most commonly held
beliefs, the concept of decisional capacity canbe subdi-
vided into four components: (1) understanding,
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(2) appreciation, (3) reasoning, and (4) choice (Appel-
baum, 2007; Appelbaum & Grisso, 1988).
Assessment of decisional capacity (DC) has been
the topic of much ongoing research. The majority of
studies focused on DC in the elderly and in those
with cognitive disorders, primarily dementia
(Etchells et al., 1999; Griffith et al., 2005; Hamann
et al., 2011; Karlawish, 2008; Marson et al., 1994;
1995; Moye et al., 2006; Raymont et al., 2004; Rodin
& Mohile, 2008; Sessums et al., 2011; Weiss et al.,
2012), and those with schizophrenia (Candilis et al.,
2008; Okai et al., 2007). Among the elderly and
cognitively impaired, validation studies of capacity
assessment tools have shown thatmild andmoderate
dementia do not exclude making informed treatment
decisions, and patients withmoderate dementia have
demonstrated DC for certain aspects of medical care
(Rodin & Mohile, 2008).
Although in some patients certain aspects of DC
are preserved, the rate of incapacitation remains
high. In nursing homes, an inability to makemedical
decisions has been found in about half the residents
(Karlawish, 2008). Another factor that has been iden-
tified as contributing to incapacity is delirium (Rodin
&Mohile, 2008; Young & Inouye, 2007). In a medical
inpatient setting, cognitive impairment has been at-
tributed to two thirds of those with decisional inca-
pacity (DI). In contrast, psychotic disorders (14%),
mood disorders (12%), and alcohol abuse disorders
(9%) were much less associated with DI.. Overall,
88% of the patients in our study were deemed to not
have DC (Kahn et al., 2009).
To date, there are very few studies on DC assess-
ment that document the associated medical and ca-
pacity questions in inpatient settings across a broad
spectrum of psychiatric disorders. In order to further
explore DC and DI in this milieu, we retrospectively
reviewed more than 2,500 psychiatric referrals to
the consultation–liaison (C–L) service at Bellevue
Hospital Center (New York) in order to evaluate the
prevalence of medical illness and psychiatric comor-
bidities and their impact on decisional capacity.
METHODS
Patients and Procedures
All cases of decisional capacity assessment were re-
viewed from psychiatric referrals to Bellevue Hospi-
tal Center between January 1, 2011 and March 31,
2012. Bellevue is a city hospital, a level one trauma
center, and the major teaching site for the
New York University School of Medicine, and it in-
cludes 450 medical and surgical beds. On average,
120,000 patients visit the adult emergency services
each year, and 26,000 inpatients receive their medi-
cal care at Bellevue. More than 80% of their patients
come from medically underserved populations.
As part of the psychiatric service, the consultation–
liaison service performs more than 2,000 initial con-
sults on the medical, surgical, and emergency care
services and about double that number of follow-up
patient contacts annually.
The C–L service maintains a clinical database
to record and track initial consults and manage re-
consultations for acute events in already-followed
patients. The reason for the consultation is also re-
corded in this database. More than 2,500 consults
(2584) were screened and 336 cases (13%) of assess-
ments of DC identified. All referrals for DC assess-
ment (signing out against medical advice, refusing
workup and treatment, as well as placement issues)
were extracted, and records were individually re-
viewed in the computer-based patient record system
(Misys CPRTM, Misys Healthcare Systems, Raleigh,
North Carolina).
We recorded such sociodemographic variables as
age and gender, psychiatric diagnoses, medical diag-
noses, reason for capacity assessment, primary treat-
ment team assessment, and psychiatric assessment.
All patients were assessed in person by residents and
attending physicians. When patients were first as-
sessed by residents, the attending physicians then
assessed the patients as part of a supervisory pro-
cess. When patients refused the initial assessment,
the refusal was recorded and another assessment un-
dertaken.
Assessments of decisional capacity were recorded
as: DC existed (“YES”) and DC did not exist (“NO”).
When patients agreed to treatment recommenda-
tions during the assessment process, this response
was recorded as “not indicated.” In a few cases, as-
sessment was not possible (as the patient had
checked out, though safety precautions had been tak-
en) or no documented record of the assessment pro-
cess could be located. These cases were recorded as
“not applicable.” When no record could be found, psy-
chiatric and medical diagnoses were extracted from
previous documentation during the same hospitali-
zation.
All psychiatric diagnoses were determined accord-
ing to theDiagnostic and Statistical Manual of Men-
tal Disorders, 4th ed. (DSM–IV–TR) (American
Psychiatric Association, 2000). Psychiatric diagnoses
were classified as psychosis, mood and cognitive dis-
orders, substance abuse disorders, mental retarda-
tion, other disorders, and none. Generally, when
psychosis was diagnosed, patients were stable and
on antipsychoticmedication; a few patients had acute
psychoses. The cognitive disorders included delirium
and dementia, as well as instances when information
or clinical impressions did not allow for a definite
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diagnosis of delirium and/or dementia. A diagnosis
of substance abuse disorder included active sub-
stance abuse prior to hospitalization (mostly alcohol,
opiates, and benzodiazepines), detoxification, and
stable/dormant substance abuse, including metha-
done maintenance.
Medical diagnoses were recorded according to
the system or service involved: cardiovascular, gas-
trointestinal, endocrine, neurological, pulmonary,
genitourinary, gynecological, infectious, oncologi-
cal, traumatological, dermatological, other, and
none. Multiple recordings of the DC assessment
in repeat cases were allowed, as well as multiple
admissions and assessments during the review pe-
riod. Recording of multiple psychiatric and medical
diagnoses according to the patient profile was also
possible, particularly in the cognitive disorder
domain.
The primary team documented DC as present or
absent. In a few cases, the primary treatment team
was unsure or no DC assessment was performed
(recorded as “not applicable”). The chart review was
approved by the institutional review board (IRB,
S-12-02375, status exempt on May 2, 2012) and the
Bellevue Central Office for data collection and
publication.
Statistical Analysis
Data analyses were performed with the Statistical
Package for the Social Sciences (SPSS, v. 20) for
Windows. Descriptive statistics were performed on
the dataset to characterize the sample sociodemo-
graphically, psychiatrically, and medically. Separate
datasets describing decisional capacity (“YES,”
“NO,” “not indicated,” and “not applicable”) were cre-
ated for our analysis of age, gender, and psychiatric/
medical diagnoses. For analysis of gender distribu-
tion, “transgender” was defined as a missing vari-
able in order to allow statistical analysis. For
analysis of completed consults, a separate dataset
reduced to “DC YES“ or “DC NO” was created. With-
in this dataset, the prevalence of psychiatric comor-
bidities in “DC YES”/“DC NO” was computed.
Prevalence rates referred to the complete “YES/
NO” sample.
A t test for independent samples was employed for
variables on the interval scale (e.g., age) and Pear-
son’s chi-square (x2) test for contingency analyses of
categorical variables. In order to assess the impact
of psychiatric diagnosis on decision-making capacity,
simple logistic regression analyses were also per-
formed. After the fact, the value of alpha (a) for all
implemented tests was adjusted using the Bonfer-
roni method. The significance level (a) was set at
p , 0.05.
RESULTS
Characteristics of Decisional Capacity
Consults
Patients assessed for decisional capacity were in
their mid-fifties and predominantly male. Psychiat-
ric and medical diagnoses were diverse; however,
there were differences in the prevalence of neurolog-
ical disorders and psychiatric comorbidities. Subjects
with neurological disorders were more often found
not to have DC thanwhenDC assessment was not in-
dicated. Most commonly, consults were called for in
patients with cognitive and substance abuse disor-
ders (42.6 and 41.3%), followed by mood disorders
(25.6%, x2 ¼ 5.76(1), p ¼ 0.019, OR ¼ 0.48), and psy-
chotic disorders (22.6%, x2 ¼ 9.62(1), p ¼ 0.003,
OR ¼ 0.45). More than 50% of cases were diagnosed
with more than one psychiatric disorder, and more
than 20% were diagnosed with three and more.
The majority of patients were not deemed to be
competent to make their own healthcare decisions.
Out of 336 DC consults, 172 patients (51.2%) were
deemed not to have decisional capacity and 94 pa-
tients (28%) were deemed to have DC. In 55 cases
(16.4%), assessment of DC was not required after
communicating the medical situation to the patient
(n ¼ 48, 87.3%), or after assessment of psychiatric co-
morbidities (n ¼ 5, 9.1%), or when no decisional as-
sessment was required (n ¼ 2, 3.6%). In 15 patients
(4.5%), an assessment could not be performed or
was not adequately documented. With the focus on
completed DC consults (N ¼ 266), nearly two thirds
of patients (64.7%) were deemed to not be able to
make their own healthcare decisions.
The primary treatment team generally employed a
different approach in the assessment of DC than that
employed in the C–L psychiatry service. Decisional
capacity was only documented in 23.8% of cases,
while 18% of patients were deemed incompetent to
make their own healthcare decisions and in 5.3%
were considered competent. Though only one fourth
of cases were assessed, the assessments by the pri-
mary medical team were often congruent with the
psychiatric assessment. In 12.8% of cases, both the
medical and psychiatric teams assessed functional
DC, and in nearly a quarter (22.8%) both teams as-
sessed DI. In contrast, the primary medical team
deemed patients to have DC in only 1.2% of cases
where the psychiatric team had assessed a lack of
DC, and in 9.6% of cases where the psychiatric
team had deemed the patient competent. Thus, the
assessments of the primary team were correct in
four of five cases; nevertheless, the primary team
did not make DC assessments in 75% of all cases
(see Table 1).
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Table 1. Sociodemographic and medical variables of decisional capacity assessments
All Patients (N ¼ 336) Yes DC (n ¼ 90) No DC (n ¼ 172) Not Indicated (n ¼ 55) Not Applicable (n ¼ 15) Statistics










1.61(185), p ¼ 0.1101
Gender (in %)
Male 71.4 67% 69.2% 79.2% 100% 8.44(3), p ¼ 0.0382
Female 28.3 33% 30.2% 21.8% –
Transgender 0.3 – 0.6% – –
Medical diagnoses (in %)
Cardiovascular 50.5 50 54.1 43.6 33.3 3.34(3), p ¼ 0.0382
Gastrointestinal 19.8 19.1 20.3 20 16.7 1.33(3), p ¼ 0.9882
Endocrine 19.2 22.3 16.3 20 33.3 3.11(3), p ¼ 0.1752
Neurological 32.4 34 37.8 14.5 25 10.70(3), p ¼ 0.0132
Pulmonary 24 24.5 21.5 32.7 16.7 3.24(3), p ¼ 0.3562
Genitourinary 13.8 12.8 14 16.4 8.3 0.69(3), p ¼ 0.8752
Gynecological 2.1 1.1 3.5 – – 3.54(3), p ¼ 0.3162
Infectious 35.7 39.4 33.7 36.4 33.3 0.88(3), p ¼ 0.3302
Oncological 15.9 14.9 15.1 18.2 25 1.11(3), p ¼ 0.7752
Traumatological 14.4 11.7 15.1 16.4 16.7 0.85(3), p ¼ 0.8382
Dermatological 12 12.8 11 12.7 16.7 0.46(3), p ¼ 0.9242
Other 18.3 30.9 26.7 29.1 26.7 4.52(3), p ¼ 0.2102
None 0.3 – 0.6 – – *
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Psychiatric Comorbidities and Decisional
Capacity
Cognitive disorders were most commonly associated
with an inability to make healthcare decisions, while
mood disorders were more often associated with hav-
ing DC. Out of the sample in which DCwas assessed,
54.1% of patients with cognitive disorders did not
have DC, contrasted with 31.9% of patients with
cognitive disorders who were able to make their
own healthcare decisions (x2 ¼ 12.0 (1), p ¼ 0.001,
OR ¼ 0.40). In mood disorders, decisional capacity
existed in 34% of subjects compared to 19.1%without
decisional capacity (x2 ¼ 10.2(1), p ¼ 0.002, OR ¼
2.55). No differences in decision-making capacity
existed in substance abuse (37.2 and 47.9%) and
psychotic disorders (25 and 22.3%).
Psychiatric comorbidities influenced the ability to
make appropriate healthcare decisions. Patients
with a cognitive disorder were much less able to
make their own decisions than patients with sub-
stance abuse or psychotic disorders (x2 ¼ 5.80(1),
p ¼ 0.018, OR ¼ 0.46, and x2 ¼ 41.59(1), p ¼ 0.000,
OR ¼ 0.061) (see Table 2).
DISCUSSION
Decisional capacityassessmentsweremost commonly
requested for patients with cognitive and substance
disorders. The majority of assessments deemed pa-
tients to not be able to make their own healthcare de-
cisions. Cognitive disorders constituted the most
common cause for being incompetent and generally
affected the ability to make healthcare decisions,
whereas mood disorders did not. In addition, cogni-
tive disorders were much more likely to impair the
ability to make appropriate healthcare decisions
than substance abuse disorders or psychosis.
These findings offer new insights into the assess-
ment of decisional capacity in psychiatric comorbidi-
ties in addition to supporting previous results (Bial
et al., 2006; Etchells et al., 1999; Fitten et al., 1990;
Freedman et al., 1991; Griffith et al., 2005; Gurrera
et al., 2006; Kahn et al., 2009; Karlawish, 2008;
Katz et al., 1995; Kim & Caine, 2002; Marson et al.,
1994; 1995; Moye et al., 2006; Rodin & Mohile,
2008; Sessums et al., 2011; Weiss et al., 2012; Young
& Inouye, 2007). Mood disorders less commonly in-
terfered with DC; in fact, DCmore often remained in-
tact. Cognitive disorders interfered more often with
the ability to make healthcare decisions than sub-
stance abuse disorders or psychosis..
Cognitive disorders are known to interfere with
the ability tomake healthcare decisions. In the elder-
ly, in patients with dementia, in nursing home resi-
dents (Barton et al., 1996; Fitten et al., 1990), and
in medical inpatients (Candilis et al., 2008; Kahn
et al., 2009; Katz et al., 1995; Kloezen et al., 1988;
Raymont et al., 2004), the capacity to make sound de-
cisions remains impaired to a substantial degree. Al-
though decision-making ability remains intact in
some patients with cognitive disorders, the degree
of incapacitation should not be underestimated in
those with less severe cognitive impairment.










(n ¼ 15) Statistics
Psychiatric
diagnoses (in %)
Psychosis 22.6 16.4 25 16.4 18.2 1.92(3), p ¼ 0.5902
Mood 25.6 34 16.9 32.7 54.5 16.72(3), p ¼ 0.0012
Cognitive
disorder
42.6 31.9 54.1 29.1 26.7 19.31(3), p ¼ 0.0002
Substance abuse 41.3 47.9 37.2 38.2 63.6 13.20(3), p ¼ 0.0042
Mental
retardation
0.9 1.7 – – – *
Other 16.4 18.1 12.2 21.8 33.3 4.52(3), p ¼ 0.2102
None 6.5 9.6 4.7 9.1 – 4.77 (3), p ¼ 0.1892
Decisional
capacity (in %)
Yes 5.1 12.8 1.2 3.6 6.7 28.40(9), p ¼ 0.001 2
No 17.3 9.6 22.7 10.9 26.7
Unsure 5.4 6.4 4.1 5.5 13.3
N/A 72.3 71.3 72.7 80 53.3
N/A ¼ not applicable; AMA ¼ against medical advice; DC ¼ decisional capacity.
2 Pearson’s chi-square test.
*Low cell count, statistical analysis not valid.
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Mood disorders, psychoses, and substance abuse
disorders in the general hospital setting have been
much less well studied. Our findings suggested that
decisional capacity was more preserved in this popu-
lation. An inability to make healthcare decisions had
previously been found to occur in 9 to 14% of patients
(Kahn et al., 2009). Our study found a 19.1% absence
of DC in mood disorders, 37.2% in substance abuse
disorders, and 25% in psychosis. This may be in
part explained by a previous underestimation of deci-
sional impairment or the fact that our sample was
more impaired, representing the medically under-
served population of Bellevue Hospital Center. An-
other factor influencing degree of DC impairment
may be the indication for and acuity of the requested
consultation. In psychiatric inpatient settings, on the
other hand, impairment of DC has been documented
at higher rates (Candilis et al., 2008; Okai et al.,
2007). Differences appeared to exist between acute
psychiatric inpatients and those with psychiatric ill-
ness in a general hospital setting with a more stable
course of illness.
Not surprisingly, neurological disorders contribut-
ed to decisional incapacity, particularly compared to
those instances in which DC assessment was not in-
dicated. One important aspect appeared to be com-
munications between healthcare provider and
patient. ADC consult was not required in 16.4% after
informing patients of the medical situation and their
available options. It has been shown that consults for
DC oftenmask a variety of psychosocial issues (Uma-
pathy et al., 1999). Communication between medical
provider and patient continues to be problematic in
certain cases, and communication skill continues to
be an ongoing topic of importance in medical care
(Coleman & Newton, 2005).
Documentation in the healthcare setting remains
critical (Sweatman, 2003). In a few cases, assessment
of decisional capacity has not been adequately docu-
mented. In even fewer cases, an assessment could not
be performed, as patients had checked out prior to as-
sessment. Medical teams do not routinely document
their DC assessments, and a structured approach is
not always recognizable. The assessment of DC as a
critical tool in providing appropriate care for patients
not able to make their own healthcare decisions may
require better physician training (Etchells et al.,
1999; Umapathy et al., 1999). In contrast, our C–L
psychiatry team routinely followed the method put
forward by Appelbaum, thus allowing for reproduc-
ible and complete assessments in this critical area
of medical care. On thewhole, the primary team’s as-
sessment of DC was rather accurate and in most in-
stances confirmed by the psychiatric service.
However, in most cases, the primary team did not
even document or assess DC.
Although our chart-review study has its strengths
in consecutively recording all patients for DC assess-
ments over a 15-month period, screening more than
2,500 consults and extracting more than 300 cases,
a number of limitations have to be noted. Our design
was not prospective, no capacity assessment rating
scales were employed, and the severity of psychiatric
illness was not recorded with standardized tools. The
population at Bellevue Hospital Center is mostly
medically underserved. The higher rates of psychiat-
ric illness and social problems may have biased our
results. Generalizability to other patient populations
may thus be limited, something that requires further
evaluation. Prospective studies with a more struc-
tured and standardized methodology are required
to validate our results.
In summary, decisional capacity assessments were
most commonly requested for patients with cognitive
and substance abuse disorders. Medically, neurologi-
cal disorders also contributed to decisional incapacity.
Among psychiatric issues, cognitive disorders were
the most common diagnosis in those with decisional
incapacity and generally affected the ability to
make healthcare decisions, whereas mood disorders
did not. Furthermore, cognitive disorders were
muchmore likely to impair the ability tomake appro-
priate healthcare decisions than substance abuse
and psychotic disorders. In the main, the primary
team’s assessment of decisional capacity was found
to be correct.
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